CRISPR Therapeutics AG short interest in 2021
In 2021, CRISPR Therapeutics AG's disclosed short interest ran from 5.15% of shares outstanding on 15 Jan 2021 to 10.52% on 31 Dec 2021, a change of +5.37 percentage points. The year's high was 10.65% on 15 Dec 2021 and its low 3.06% on 15 Jul 2021, averaging 5.48% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.09 days on 31 Dec 2021. Full history: CRISPR Therapeutics AG.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 5.15% (15 Jan 2021)
- End of year
- 10.52% (31 Dec 2021)
- Change
- +5.37 pp
- High
- 10.65% (15 Dec 2021)
- Low
- 3.06% (15 Jul 2021)
- Average
- 5.48%
- Highest days to cover
- 5.09 (31 Dec 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 5.15% | 1.49 | |
| 29 Jan 2021 | 4.17% | 1.41 | |
| 12 Feb 2021 | 4.04% | 1.49 | |
| 26 Feb 2021 | 4.98% | 1.72 | 10-K filed, results (8-K) |
| 15 Mar 2021 | 5.60% | 1.66 | |
| 31 Mar 2021 | 5.91% | 3.05 | |
| 15 Apr 2021 | 5.63% | 3.99 | |
| 30 Apr 2021 | 4.56% | 2.27 | 10-Q filed, results (8-K) |
| 14 May 2021 | 5.11% | 2.41 | |
| 28 May 2021 | 4.38% | 3.69 | |
| 15 Jun 2021 | 4.44% | 3.33 | |
| 30 Jun 2021 | 4.24% | 1.65 | |
| 15 Jul 2021 | 3.06% | 1.78 | |
| 30 Jul 2021 | 3.39% | 2.32 | 10-Q filed, results (8-K) |
| 13 Aug 2021 | 3.85% | 2.23 | |
| 31 Aug 2021 | 3.89% | 3.40 | |
| 15 Sep 2021 | 4.16% | 3.58 | |
| 30 Sep 2021 | 3.50% | 2.63 | |
| 15 Oct 2021 | 6.33% | 2.21 | |
| 29 Oct 2021 | 7.33% | 4.23 | |
| 15 Nov 2021 | 7.65% | 4.12 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 9.07% | 4.93 | |
| 15 Dec 2021 | 10.65% | 4.63 | |
| 31 Dec 2021 | 10.52% | 5.09 |
See also: CRISPR Therapeutics AG's full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.